Royalty Pharma presents at J.P. Morgan; no financial details in filing

Royalty Pharma plc

Presentation at 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.
Filing references a pending corporate simplification transaction (see Jan 10, 2025 8-K).
No financial results, guidance, or portfolio updates provided in this exhibit.
Shareholder vote required for transaction; proxy statement to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.